SBME Research Day
SBME Research Day is an opportunity for our community of faculty, trainees, and staff to come together, discuss SBME priorities, and share their research through a poster session, trainee talks, and lunch. Save the date! More event details to come.
Events
Calendar
Research Seminar: Internal Speaker Series – Dr. Joel Finbloom – Directing the microbe-material interface to treat infections and inflammatory disease
Zoom Meeting ID: 693 4383 4453
Passcode: 608808
Location:
SHRM B1001, Gordon B. Shrum Building
Talk title: Directing the microbe-material interface to treat infections and inflammatory disease
Abstract: Guiding the interactions between a material and a biological system of interest, termed the material biointerface, is critical for applications in drug delivery. In this presentation, I will discuss recent projects in engineering nanomaterial properties to direct microbe-material interactions for applications in infectious disease and inflammation. These include our work designing dynamic stimuli-responsive nanoparticles for the co-delivery of antimicrobials to treat bacterial biofilm infections, as well as recent efforts in engineering biofilm-inspired nanomaterials to advance the encapsulation and delivery of probiotics for ulcerative colitis treatment.
Dr. Joel Finbloom‘s biography:
Dr. Joel Finbloom is an Assistant Professor of Pharmaceutical Sciences and associate faculty member in the School of Biomedical Engineering at the University of British Columbia. The Finbloom lab designs bioinspired materials that interface with microbial communities to advance human health. By working at the intersection of chemical biology, nanotechnology, and bioengineering, the Finbloom lab tackles critical challenges in the pharmaceutical sciences.
Dr. Finbloom started his scientific career at the NIH in 2008, where he worked at the National Institute of Allergy and Infectious Diseases to develop cancer immunotherapies. Dr. Finbloom received his BA in chemistry in 2013 from Northwestern University and his PhD in chemistry in 2018 from the University of California Berkeley, working in the fields of nanomedicine and chemical biology for applications in drug delivery and disease diagnostics. Dr. Finbloom then completed his postdoctoral fellowship at the University of California San Francisco, engineering drug carriers for applications in infectious disease and regenerative medicine.